Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Thigh muscle weakness in osteomalacia stems from a proximal myopathy driven by vitamin D deficiency, along with low calcium and phosphate levels that impair muscle fiber contraction and energy production, often worsened by secondary hyperparathyroidism. The physical signs your doctor looks for include a waddling gait, difficulty rising from a chair or climbing stairs without using the arms, a positive Trendelenburg sign, reduced muscle tone with preserved reflexes, and tenderness when pressure is applied over the pelvis, hips, or ribs. Because softened bone and weakened muscle occur together, pain and weakness frequently overlap, which can mask the true cause and delay diagnosis. Several factors influence how these signs present, including how long the deficiency has lasted, kidney function, and medication use. See below to understand more before assuming your symptoms are simply fatigue or aging.
Understanding whether your leg weakness points to a metabolic bone problem or something else matters, since the workup and treatment differ sharply. A free, instant, online symptom check can help you organize what you are feeling, flag findings worth mentioning to your doctor, and clarify how urgently you should be seen.
Last reviewed for medical accuracy: 08/18/2026
Osteomalacia is a condition characterized by softening of the bones due to poor mineralization, most often from vitamin D deficiency. While many people focus on bone pain and fractures, thigh muscle weakness—and specifically proximal muscle weakness difficulty standing from chair—is a hallmark sign that often leads patients to seek medical attention. Understanding why this happens and which physical signs to watch for can help you recognize the problem early and get the care you need.
Impaired Mineral Metabolism
Direct Muscle Cell Impact
Reduced Physical Activity
Your hip and thigh muscles (quadriceps, gluteals) handle most of the effort when you rise from a seated position. In osteomalacia:
This proximal muscle weakness difficulty standing from chair is often one of the first clues you or your doctor will notice.
When you visit your healthcare provider, they may perform one or more of these simple tests:
Chair Rise Test
Sit in a standard chair with arms across your chest. Try to stand up without using your hands.
• In osteomalacia, you may need to push off with your hands or rock your torso forward.
• Count how many times you can rise in 30 seconds; fewer than 10 can indicate weakness.
Gait Observation
Watch for a waddling or “duck-like” gait.
• The torso may shift side to side to compensate for hip muscle weakness.
Trendelenburg Sign
The doctor asks you to stand on one leg.
• A positive sign is a drop of the opposite hip, showing gluteal muscle weakness.
Gower’s Sign
Though classically described in muscular dystrophy, mild Gower’s maneuver (using hands to “walk” up thighs when rising) can occur in osteomalacia if proximal weakness is severe.
Your doctor will want to confirm that muscle weakness and bone discomfort are due to osteomalacia rather than other causes:
Blood Tests
Imaging
Additional Evaluation
If you’re experiencing proximal muscle weakness difficulty standing from chair and bone pain, it’s important to rule out osteomalacia promptly.
Once osteomalacia is diagnosed, treatment focuses on restoring normal vitamin D and mineral levels:
Vitamin D Supplements
• High-dose vitamin D2 or D3 under medical supervision.
• Follow-up blood tests to guide maintenance dosing.
Calcium and Phosphorus
• Oral supplements as needed.
• Dietary changes to include dairy, fatty fish, fortified foods.
Sunlight Exposure
• Short, regular sun exposure helps skin produce vitamin D.
• Balance sun safety with adequate UVB contact.
Physical Therapy
• Targeted exercises to strengthen hip and thigh muscles.
• Gradual walking, resistance training, and chair-rise practice.
With treatment, many people see improvement in muscle strength within weeks to months. However, full recovery of bone density may take longer.
Keep track of your symptoms and discuss any ongoing issues with your doctor. You may notice:
Regular follow-up appointments and lab tests ensure you’re on the right track.
If you experience any of the following, see a healthcare professional promptly:
For an initial assessment, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Osteomalacia is treatable, but delayed diagnosis can lead to fractures and prolonged disability. Always speak to a doctor if you have concerns about muscle weakness, bone pain, or any symptom that could be life-threatening or serious.
(References)
* Ruff RL, Weissmann J. Endocrine myopathies. Neurol Clin. 1988 Aug;6(3):575-92. PMID: 3065602.
* Francis RM, Selby PL. Osteomalacia. Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):145-63. doi: 10.1016/s0950-351x(97)80569-1. PMID: 9222490.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011 Jun;18(3):R53-77. doi: 10.1530/ERC-11-0006. Epub 2011 Jun 8. PMID: 21490240; PMCID: PMC3433741.
* Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):585-91. doi: 10.1016/j.beem.2011.05.002. PMID: 21872800.
* Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT. Tumour-induced osteomalacia. Nat Rev Dis Primers. 2017 Jul 13;3:17044. doi: 10.1038/nrdp.2017.44. Epub 2017 Jul 13. PMID: 28703220.
* Florenzano P, Gafni RI, Collins MT. Tumor-induced osteomalacia. Bone Rep. 2017 Dec;7:90-97. doi: 10.1016/j.bonr.2017.09.002. Epub 2017 Sep 20. PMID: 29021995; PMCID: PMC5633085.
* Haffner D, Leifheit-Nestler M, Grund A, Schnabel D. Rickets guidance: part I-diagnostic workup. Pediatr Nephrol. 2022 Sep;37(9):2013-2036. doi: 10.1007/s00467-021-05328-w. Epub 2021 Dec 15. PMID: 34910242; PMCID: PMC9307538.
* Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL, Tiegs RD, Sfeir J, DeLone DR. Phosphaturic Mesenchymal Tumor. AJNR Am J Neuroradiol. 2022 Jun;43(6):817-822. doi: 10.3174/ajnr.A7513. Epub 2022 May 19. PMID: 35589138; PMCID: PMC9172954.
* Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML, Clifton-Bligh R, Collins M, Florenzano P, Houillier P, Imanishi Y, Imel EA, Khan AA, Zillikens MC, Fukumoto S. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13. PMID: 36511653; PMCID: PMC10108006.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.